| Filed On | Filing |
|---|---|
| 28 Sep 2026 |
8-K: Other Events
Fate Therapeutics Announces Receipt of California Institute for Regenerative Medicine (CIRM) CLIN2 Grant to Advance RECLAIM-LN |
| 13 Aug 2026 | S-8 |
| 13 Aug 2026 | 10-Q |
| 13 Aug 2026 | 8-K: Results of Operations and Financial Condition |
| 05 Aug 2026 |
Form 4: Tahl Cindy, See Remarks
Sold 38,800 shares ($95.4K) |
| 05 Aug 2026 |
Form 4: Valamehr Bahram, Director
Sold 43,947 shares ($108K) |
| 04 Aug 2026 | 144 |
| 04 Aug 2026 | 144 |
| 08 Jul 2026 | SCHEDULE 13G/A |
| 15 Jun 2026 |
Form 4: Redmile Group, Llc, Director and 1 other
Granted 87,900 Stock Option (Right to Buy) |
| 15 Jun 2026 |
Form 4: Lee Michael Stewart, Director
Granted 87,900 Stock Option (Right to Buy) |
| 15 Jun 2026 |
Form 4: Xu Yuan, Director
Granted 87,900 Stock Option (Right to Buy) |
| 15 Jun 2026 |
Form 4: Jooss Karin, Director
Granted 87,900 Stock Option (Right to Buy) |
| 15 Jun 2026 |
Form 4: Epstein Robert S, Director
Granted 87,900 Stock Option (Right to Buy) |
| 15 Jun 2026 |
Form 4: Agarwal Shefali, Director
Granted 87,900 Stock Option (Right to Buy) |
| 15 Jun 2026 |
Form 4: Abernethy Matt, Director
Granted 87,900 Stock Option (Right to Buy) |
| 15 Jun 2026 |
Form 4: Rastetter William H, Director
Granted 87,900 Stock Option (Right to Buy) |
| 15 Jun 2026 |
Form 4: Hamill Laura, Director
Granted 175,800 Stock Option (Right to Buy) |
| 15 Jun 2026 |
Form 3: Hamill Laura, Director
No securities owned |
| 15 Jun 2026 | 8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders |
Loading...
